118897-99-7

Usage

Uses

Used in Pharmaceutical Synthesis:
5-Bromo-6-fluoroindoline-2,3-dione serves as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs with potential therapeutic benefits.
Used in Agrochemical Synthesis:
5-broMo-6-fluoroindoline-2,3-dione is also utilized as an intermediate in the production of agrochemicals, playing a crucial role in the creation of effective pesticides and other agricultural products.
Used in Organic Synthesis:
5-Bromo-6-fluoroindoline-2,3-dione is employed in organic synthesis, where its unique structure and properties enable the development of novel organic compounds for various applications.
Used in Material Science:
In the field of material science, 5-broMo-6-fluoroindoline-2,3-dione has been investigated for its potential use in creating new materials with specific properties, such as improved stability or reactivity.
Used in Biological Research:
5-Bromo-6-fluoroindoline-2,3-dione has been studied for its potential biological activities, including anti-inflammatory and antifungal properties, making it a promising candidate for further research in the development of new therapeutic agents.

Upstream product

• 777-65-1 (E)-N-(4-bromo-3-fluorophenyl)-2-(oximido)acetamide 
• 515-83-3 chloral ethyl hemiacetal 
• 656-65-5 3-fluoro-4-bromophenylamine 

Downstream Products

• 1360928-47-7 5-bromo-6-fluoro-1H-indazole-3-carboxylic acid 

Relevant academic research and scientific papers

SYK INHIBITOR AND USE METHOD THEREFOR

Provided are a Syk inhibitor and a use method therefor, and in particular, disclosed are quinolinone represented by formula (I) or quinazoline derivatives or pharmaceutically acceptable salts thereof, a preparation method, a pharmaceutical composition, and uses in preparing a medicament for treatment of Syk receptor related diseases.

5-HETEROARYL SUBSTITUTED INDAZOLE-3-CARBOXAMIDES AND PREPARATION AND USE THEREOF

Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, Darier's disease, scleroderma, cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as neurological conditions/disorders/diseases linked to overexpression of DYRK1A.

5-SUBSTITUTED INDAZOLE-3-CARBOXAMIDES AND PREPARATION AND USE THEREOF

Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, fibrotic disorders, cartilage (chondral) defects, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, and neurological conditions/disorders/diseases linked to overexpression of DYRK1A.